Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

被引:244
作者
Chabaud, M
Garnero, P
Dayer, JM
Guerne, PA
Fossiez, F
Miossec, P [1 ]
机构
[1] Hop Edouard Herriot, Dept Immunol, Clin Immunol Unit, F-69437 Lyon 03, France
[2] Fac Med Laennec, Dept Immunol, Lyon, France
[3] Fac Med Laennec, Dept Rheumatol, Lyon, France
[4] Fac Med Laennec, INSERM, U403, Lyon, France
[5] Div Immunol & Allergy, Geneva, Switzerland
[6] Div Rheumatol, Geneva, Switzerland
[7] Schering Plough Lab Immunol Res, Dardilly, France
关键词
collagenase; C-terminal collagen cross-links; IL-17; rheumatoid arthritis; synovium;
D O I
10.1006/cyto.2000.0681
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL-)17 is a T cell-derived pro-inflammatory cytokine produced by RA synovium, We studied the role of IL-17 in the synovium cytokine network to determine whether it can influence the inflammatory and destructive pattern characteristic of RA. Herein, we investigated whether the production and action of MMP-1 and its inhibitor TIMP-1 could be modulated by IL-17 in the presence of pro-inflammatory cytokine (IL-1) and anti-inflammatory cytokines (IL-4, IL-13, IL-10), The effect of the blockade of endogenous IL-17 on the secretion of MMP-1 and TIMP-1 by IU synovium and matrix destruction was also studied. IL-17 increased the spontaneous production of MMP-1 by synoviocytes five-fold. IL-1 was more potent since it increased MMP-1 production nine-fold, Addition of IL-4, IL-13 and IL-10 to synoviocyte cultures reduced the spontaneous production of MMP-1 and induced TIMP-1 production by synoviocytes stimulated with IL-17 or/and IL-1 beta In the presence of anti-IL-17 blocking mAb, MMP-1 production and collagenase activity by RA synovium was reduced by 50% and associated with a 50% reduction in type I collagen C-telopeptide fragments (CTS) released in the supernatants, demonstrating the direct contribution of IL-17 in destruction. IL-17 and its producing T cells appear to contribute to the inflammatory process involved in the rheumatoid lesion. (C). 2000 Academic Press.
引用
收藏
页码:1092 / 1099
页数:8
相关论文
共 30 条
[1]  
AARWAK T, 1997, J IMMUNOL, V162, P1246
[2]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[3]   INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[4]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[5]   Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage [J].
Attur, MG ;
Patel, RN ;
Abramson, SB ;
Amin, AR .
ARTHRITIS AND RHEUMATISM, 1997, 40 (06) :1050-1053
[6]   Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen [J].
Bonde, M ;
Garnero, P ;
Fledelius, C ;
Qvist, P ;
Delmas, PD ;
Christiansen, C .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (07) :1028-1034
[7]  
Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO
[8]  
2-E
[9]  
Chabaud M, 1998, J IMMUNOL, V161, P409
[10]  
DAYER JM, 1994, EUR CYTOKINE NETW, V5, P563